Investigative Ophthalmology & Visual Science, Vol 34, 3194-3198, Copyright © 1993 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Nonocular Chlamydia infection and risk of ocular reinfection after mass treatment in a trachoma hyperendemic area

S West, B Munoz, L Bobo, TC Quinn, H Mkocha, M Lynch, BB Mmbaga and R Viscidi
Dana Center for Preventive Ophthalmology, Johns Hopkins University, Baltimore, Maryland.

PURPOSE. The presence of nasal discharge on a child's face increases the risk of active trachoma, suggesting that Chlamydia trachomatis in nasal secretions may be a possible source of ocular reinfection. The prevalence of chlamydia in nasal secretions and the risk of reinfection after mass treatment was investigated in a hyperendemic area of Tanzania. METHODS. In one village a total of 232 children aged 1 to 7 years were followed before and after mass treatment. Clinical trachoma, and microbiologic evidence of chlamydia, were assessed at baseline, 2 and 4 weeks into mass treatment, and 4 weeks after treatment stopped. The presence of chlamydia in ocular and nasal secretions was determined by polymerase chain reaction-enzyme immunoassay techniques. RESULTS. Of the 232 children, 59% had clinical trachoma and 27% had nasal specimens positive for chlamydia. Children with positive ocular chlamydia specimens and/or clinical trachoma were significantly more likely to have positive nasal specimens. At the end of mass treatment, only 4% of children had positive ocular specimens. However, 1 month after treatment stopped, the incidence of new infection was 21%. The rate of new ocular infections in those who had negative ocular specimens after treatment was similar between those who had positive and those who had negative nasal specimens at baseline. Positive ocular specimens at baseline was not a predictor of risk of new infection after treatment (odds ratio = 1.18, 95% confidence interval = 0.58, 2.40), suggesting these new infections were not the result of latent or persistent organism. CONCLUSIONS. These data do not support a role for nasal secretions in causing reinfection after treatment. One mass topical treatment alone is unlikely to be effective in trachoma hyperendemic areas as shown by the rapid re-emergence of infection.

This article has been cited by other articles:

				E. W. Gower, A. W. Solomon, M. J. Burton, A. Aguirre, B. Munoz, R. Bailey, M. Holland, P. Makalo, P. Massae, H. Mkocha, et al. Chlamydial Positivity of Nasal Discharge at Baseline Is Associated with Ocular Chlamydial Positivity 2 Months following Azithromycin Treatment Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4767 - 4771. [Abstract] [Full Text] [PDF]

				H Zhang, R P Kandel, H K Atakari, and D Dean Impact of oral azithromycin on recurrence of trachomatous trichiasis in Nepal over 1 year Br. J. Ophthalmol., August 1, 2006; 90(8): 943 - 948. [Abstract] [Full Text] [PDF]

				A. W. Solomon, R. W. Peeling, A. Foster, and D. C. W. Mabey Diagnosis and Assessment of Trachoma Clin. Microbiol. Rev., October 1, 2004; 17(4): 982 - 1011. [Abstract] [Full Text] [PDF]

				H. Zhang, R. P. Kandel, B. Sharma, and D. Dean Risk Factors for Recurrence of Postoperative Trichiasis: Implications for Trachoma Blindness Prevention Arch Ophthalmol, April 1, 2004; 122(4): 511 - 516. [Abstract] [Full Text] [PDF]

				S. K. WEST BLINDING TRACHOMA: PREVENTION WITH THE SAFE STRATEGY Am J Trop Med Hyg, November 1, 2003; 69(2007): 18 - 23. [Abstract] [Full Text] [PDF]

				T. Lietman and A. Fry Can we eliminate trachoma? Br. J. Ophthalmol., April 1, 2001; 85(4): 385 - 387. [Full Text]

				Y.-H. Hsieh, L. D. Bobo, T. C. Quinn, and S. K. West Risk Factors for Trachoma: 6-Year Follow-up of Children Aged 1 and 2 Years Am. J. Epidemiol., August 1, 2000; 152(3): 204 - 211. [Abstract] [Full Text] [PDF]